Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 21.73 as of Saturday, August 1, 2026.
Forward PE Ratio (21.73) = Close Price ($325.70) / Consensus Forward EPS ($14.99)
FORWARD PE RATIO
21.73
SECTOR MEDIAN · HEALTHCARE
19.07
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+13.98%
vs the sector median at left
Stryker Corporation
Market Cap
$124.86B
Forward PE Ratio
21.73
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Stryker Corporation (SYK) | $124.86B | 21.73 |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 32.72 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 24.81 |
| AstraZeneca PLC (AZN)vs › | $131.47B | 16.55 |
| CVS Health Corp. (CVS)vs › | $133.25B | 14.02 |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 9.88 |
| Danaher Corporation (DHR)vs › | $137.13B | 22.96 |
| Medtronic plc (MDT)vs › | $109.30B | 15.47 |
| Pfizer Inc. (PFE)vs › | $142.54B | 8.50 |
| GSK plc (GSK)vs › | $103.56B | 14.48 |
Trailing P/E
33.8
reported TTM EPS
Forward P/E
21.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.99 implies +55.3% EPS growth vs the reported trailing $9.65.
At today's $325.70 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.99 | $14.86 – $15.08 | 16 | 21.7x |
| 2027-12-31 | $16.75 | $15.52 – $17.07 | 16 | 19.4x |
| 2028-12-31 | $18.65 | $17.38 – $20.38 | 8 | 17.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
